Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Mesothelioma × Vitamin B 12 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 4 Neoplasm Metastasis 3 Lung Neoplasms 3 Stomatitis 2 Recurrence 2 Nasopharyngeal Carcinoma 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Vitamin B 12 Deficiency 1 Urinary Bladder Neoplasms 1 Thyroid Diseases 1 Stomach Neoplasms 1 Smoking 1 Peripheral Nervous System Diseases 1 Oligodendroglioma 1 Nasopharyngeal Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, B-Cell 1 Laryngeal Diseases 1 Gliosarcoma 1 Glioblastoma 1 Central Nervous System Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Brain Edema 1 Astrocytoma 1

Interventions

Pemetrexed 10 Gemcitabine 8 Cisplatin 8 Nivolumab 4 Carboplatin 4 niraparib 3 durvalumab 3 Vinorelbine 3 Ipilimumab 3 Bevacizumab 3 tremelimumab 2 pembrolizumab 2 olaparib 2 anetumab ravtansine 2 Radiotherapy, Intensity-Modulated 2 Imatinib Mesylate 2 Fluorodeoxyglucose F18 2 vandetanib 1 tazemetostat 1 sargramostim 1 ribociclib 1 fludarabine phosphate 1 fludarabine 1 dostarlimab 1 defactinib 1 decitabine and cedazuridine drug combination 1 bintrafusp alfa protein, human 1 Zoledronic Acid 1 Vitamin B 12 1 Valproic Acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01569919 2013-03-12

SKOPOS

Wales Cancer Trials Unit

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡